Cargando…
Utility of Stimulated Thyroglobulin in Reclassifying Low Risk Thyroid Cancer Patients’ Following Thyroidectomy and Radioactive Iodine Ablation: A 7-Year Prospective Trial
CONTEXT: Following total thyroidectomy and radioactive iodine (RAI) ablation, serum thyroglobulin levels should be undetectable to assure that patients are excellent responders and at very low risk of recurrence. OBJECTIVE: To assess the utility of stimulated (sTg) and non-stimulated (nsTg) thyroglo...
Autores principales: | Jammah, Anwar A., Masood, Afshan, Akkielah, Layan A., Alhaddad, Shaimaa, Alhaddad, Maath A., Alharbi, Mariam, Alguwaihes, Abdullah, Alzahrani, Saad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7945948/ https://www.ncbi.nlm.nih.gov/pubmed/33716951 http://dx.doi.org/10.3389/fendo.2020.603432 |
Ejemplares similares
-
Quantitative thyroglobulin response to radioactive iodine treatment in predicting radioactive iodine-refractory thyroid cancer with pulmonary metastasis
por: Wang, Chen, et al.
Publicado: (2017) -
Reclassifying variations of unknown significance in diseases affecting Saudi Arabia’s population reveal new associations
por: Al Eissa, Mariam M., et al.
Publicado: (2023) -
Comparing the efficacy of thyroglobulin and thyroglobulin/ thyroid-stimulating hormone ratio models in predicting a successful response to radioactive iodine therapy
por: Ju, Yanli, et al.
Publicado: (2023) -
Radioactive Iodine Remnant Ablation: The Beta-knife Completion Thyroidectomy
por: Gulec, Seza, et al.
Publicado: (2017) -
Preablative Stimulated Thyroglobulin and Thyroglobulin Reduction Index as Decision-Making Markers for Second Radioactive Iodine Therapy in Patients with Structural Incomplete Response
por: Wang, Lihua, et al.
Publicado: (2021)